The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic

Sonnenborn, Ulrich, Schulze, Jürgen·2009·Microbial Ecology in Health and Disease

Cites (252)

Items 201–252 of 252

  1. Probiotics: From Functional Foods to Pharmaceutical Products
    Tripta Bansal, Sanjay Garg · 2008 · Current Pharmaceutical Biotechnology
  2. Probiotics
    Stephan Karl Böhm, Wolfgang Kruis · 2006 · Annals of the New York Academy of Sciences
  3. Origin and characteristics of enteroinvasive strains of Escherichia coli (EIEC) isolated in Germany
    Lothar Beutin, Kerstin Gleier, I Kontny, Peter D. Echeverria, Flemming Scheutz · 1997 · Epidemiology and Infection
  4. Intestinal flora in health and disease.
    Helmut Haenel, Justin Bendig · 1975 · PubMed
  5. Are probiotics detectable in human feces after oral uptake by healthy volunteers?
    Martina Prilassnig, Christoph Wenisch, Florian Daxboeck, Gebhard Feierl · 2007 · Wiener klinische Wochenschrift
  6. How science will help shape future clinical applications of probiotics
    M. Heselmans, Mike Reid, Louis M. A. Akkermans, H.F.J. Savelkoul, Harro M. Timmerman, F.M. Rombouts · 2005 · Scholarship@Western (Western University)
  7. Development of a tripartite vector system for live oral immunization using a Gram-negative probiotic carrier
    Christian Buddenborg, Damini Daudel, Shanti Liebrecht, Lilo Greune, Verena Humberg, Marcus Alexander Schmidt · 2007 · International Journal of Medical Microbiology
  8. Successful treatment of gut-caused halitosis with a suspension of living non-pathogenic Escherichia coli bacteria- a case report
    Jobst Henker, Frank Schuster, Karl Nissler · 2001 · European Journal of Pediatrics
  9. Probiotische Arzneimitteltherapie mit E. coli Stamm Nissle 1917 (EcN): Ergebnisse einer prospektiven Datenerhebung mit 3807 Patienten
    Heinz J. Krammer, H Kämper, R von Bünau, Egmont Zieseniß, Christiane Stange, F. Schlieger, I Clever, J Schulze · 2006 · Zeitschrift für Gastroenterologie
  10. Host gene expression in the colon of gnotobiotic interleukin-2-deficient mice colonized with commensal colitogenic or noncolitogenic bacterial strains: Common patterns and bacteria strain specific signatures
    Erwin Bohn, Oliver Bechtold, Naima Zahir, Julia-Stefanie Frick, Jörg Reimann, Burghart Jilge, Ingo B. Autenrieth · 2006 · Inflammatory Bowel Diseases
  11. The Antagonism of Coliform Bacteria Against Shigellae
    Seymour P. Halbert · 1948 · The Journal of Immunology
  12. Pulsed-Field Gel Electrophoresis
    Margit Burmeister, Levy E. Ulanovsky · 1992 · Humana Press eBooks
  13. Probiotics in the Treatment of Human Inflammatory Bowel Diseases
    Richard Neil Fedorak, Levinus Albert Dieleman · 2008 · Journal of Clinical Gastroenterology
  14. Differential Immunomodulating Effects of Inactivated Probiotic Bacteria on the Allergic Immune Response
    Claudia Rasche, Christopher Wolfram, Michael Wahls, Margitta Worm · 2007 · Acta Dermato Venereologica
  15. Clonal analysis of Escherichia coli serotype O6 strains from urinary tract infections
    Gerhard Zingler, Manfred Ott, Gabriele Blum, Ursula Falkenhagen, Günter Naumann, Wanda Sokolowska‐Köhler, Jörg Hacker · 1992 · Microbial Pathogenesis
  16. Pulsed field gel electrophoresis; Protocols, methods and theories
    1993 · International Journal of Biochemistry
  17. Sensitivity to Escherichia coli Nissle 1917 in mice is dependent on environment and genetic background
    André Bleich, John P. Sundberg, Anna Smoczek, Reinhard von Wasielewski, Maike F. de Buhr, Lydia M. Janus, Gwen Julga, Sya N. Ukena, H J Hedrich, Florian Gunzer · 2007 · International Journal of Experimental Pathology
  18. Antibiotic resistance origins, evolution, selection and spread, Ciba Foundation Symposium 207
    S Levy · 1997 · Public Health
  19. Probiotics for Mother and Child
    Gregor Reid, Estelle Devillard · 2004 · Journal of Clinical Gastroenterology
  20. Can phage defence maintain colicin plasmids in Escherichia coli
    Michael Feldgarden, S. Golden, H. Wilson, M. A. Riley · 1995 · Microbiology
  21. A Mesocosm of Lactobacillus johnsonii , Bifidobacterium longum , and Escherichia coli in the Mouse Gut
    Emmanuel Denou, Enea Rezzonico, Jean-Michel Panoff, Fabrizio Arigoni, Harald Brüssow · 2009 · DNA and Cell Biology
  22. Probiotics in Gastroenterology
    Premysl Fric · 2002 · Zeitschrift für Gastroenterologie
  23. Effects of monocolonization withEscherichia coli strains O6K13 and nissle 1917 on the development of experimentally induced acute and chronic intestinal inflammation in germ-free immunocompetent and immunodeficient mice
    Tomáš Hudcovic, Renáta Štëpánková, Hana Kozáková, Tomáš Hrnčíř, Helena Tlaskalová‐Hogenová · 2007 · Folia Microbiologica
  24. Clonal differentiation of uropathogenic Escherichia coli isolates of serotype O6:K5 by fimbrial antigen typing and DNA long-range mapping techniques
    Gerhard Zingler, Gabriele Blum, Ursula Falkenhagen, Ida Ørskov, Frits Ørskov, J�rg Hacker, Manfred Ott · 1993 · Medical Microbiology and Immunology
  25. Augmentation of host defence against bacterial and fungal infections of mice pretreated with the non-pathogenic Escherichia coli strain Nissle 1917.
    Stefan Hockertz · 1997 · PubMed
  26. Transcriptional regulation through RfaH contributes to intestinal colonization by<i>Escherichia coli</i>
    Nagy, Gábor, Dobrindt, Ulrich, Grozdanov, Lubomir, Hacker, Jörg, Emődy, Levente · 2005 · FEMS Microbiology Letters
  27. The minipig as a model in gnotobiology
    Leos Mandel, Jiri Travnicek · 1987 · Food / Nahrung
  28. Local and serum antibody response in full–term and premature infants after artificial colonization of the intestine with E. coli strain Nissle 1917 (Mutaflor®)
    R. Lodinová–Žaadniková, Helena Tlaskalová-Hogenová, Ulrich Sonnenborn · 1992 · Pediatric Allergy and Immunology
  29. Living Drugs for Gastrointestinal Diseases: The Case for Probiotics
    Philippe R. Marteau · 2006 · Digestive Diseases
  30. Probiotika in der Therapie des Reizdarmsyndroms
    Heiner Krammer, F. Schlieger, Hermann Harder, A Franke, M. V. Singer · 2005 · Zeitschrift für Gastroenterologie
  31. Current Biological Therapies for Inflammatory Bowel Disease
    Daniel Baumgart, Axel U Dignass · 2004 · Current Pharmaceutical Design
  32. Stimulation of Intestinal Immune Cells By E. coli in Gnotobiotic Piglets
    Leos Mandel, I Trebichavský, Igor Šplı́chal, Jürgen Schulze · 1995 · Advances in experimental medicine and biology
  33. Probiotics and Inflammatory Bowel Disease
    John H. Kwon, Richard J. Farrell · 2003 · BioDrugs
  34. Probiotische Therapie einer pseudomembranösen Kolitis: Kombinatiion aus intestinaler Lavage und oraler Gabe von Escherichia coli
    Karl J. Goerg, E Schlörer · 2008 · DMW - Deutsche Medizinische Wochenschrift
  35. Host Interception of Bacterial Communication Signals
    Alexander R. Horswill, William Michael Nauseef · 2008 · Cell Host & Microbe
  36. Specific regions of genome plasticity and genetic diversity of the commensal Escherichia coli A0 34/86
    Jana Holubová, Pagès Delphine, Christophe Rusniok, Philippe Glaser, Peter Šebo, Carmen Buchrieser · 2006 · International Journal of Medical Microbiology
  37. In vivo effects of mesalazine or E. coli Nissle 1917 on microsatellite instability in ulcerative colitis
    Ajay Goel, A. MITTAL, Rayko Evstatiev, Manuela Nemeth, Wolfgang Kruis, Moritz Stolte, Clement Richard Boland, Christoph Gasché · 2009 · Alimentary Pharmacology & Therapeutics
  38. K-Antigen Identification, Hemolysin Production, and Hemagglutination Types of Escherichia coli 06 Strains Isolated from Patients with Urinary Tract Infections
    Gerhard Zingler, Günter Schmidt, Ida Ørskov, Frits Ørskov, Ursula Falkenhagen, Günter Naumann · 1990 · Zentralblatt für Bakteriologie
  39. The ecological digestive system and its colonisation
    Dwayne C. Savage · 1989 · Scientific and Technical Review (World Organisation for Animal Health)
  40. Influence of E. coli strain Nissle 1917 (EcN) on intestinal gas dynamics and abdominal sensation
    Hernando-Harder, Ana Cristina, von Bünau, Rudolf, Nadarajah, Mahaluxmy, Singer, Manfred Vincenz, Harder, Hermann · 2008 · Digestive Diseases and Sciences
  41. Therapy with E.coli nissle reduces concentrations of mucosa associated colonic flora in patients with ulcerative colitis
    Alexander V. Swidsinski, Sonja Swidsinski, Andrej Godzun, Marianne Orthner, Herbert H. Lochs · 2000 · Gastroenterology
  42. Inhibition of Salmonella typhimurium invasion into intestinal cells by the probiotic E. coli strain Nissle 1917
    Tobias A. Oelschlaeger, Artur Altenhoefer, Joerg Hacker · 2001 · Gastroenterology
  43. Novel Biological Strategies in Inflammatory Bowel Diseases
    Séverine Vermeire, Paul J. Rutgeerts · 2004 · Inflammatory Bowel Diseases
  44. Über Hauterscheinungen bei Aspiringebrauch
    Alfred Kraus · 1914 · Archives of Dermatological Research
  45. Transfection of E. coli with lambda DNA by electroporation.
    Claudio Magistrelli, E Colombo, A. Tognoni, G Grandi · 1992 · PubMed
  46. A new approach in pseudomembranous colitis: probiotic Escherichia coli Nissle 1917 after intestinal lavage
    Karl J. Goerg, Mariola Wybierala, Jutta Rauen-Vossloh, Claus Hader · 2008 · European Journal of Gastroenterology & Hepatology
  47. Postinfective bowel dysfunction
    Robert E. Spiller · 1997 · Current Opinion in Gastroenterology
  48. Maintenance Therapy
    Wolfgang Kruis, Stefan Schreiber · 2004 · Zeitschrift für Gastroenterologie
  49. Helicobacter meets inflammatory bowel disease
    孝 下山 · 2002 · Medical Entomology and Zoology
  50. P320 - Antimutagenic activity of the probiotic E. coli strain Nissle 1917
    Ulrich Sonnenborn, D. Janosch, Silke Dubbert, Thomas Stroff, L. Schulze, Hartwig Müller · 2009 · Journal of Crohn s and Colitis
  51. Therapeutische Wirksamkeit des probiotischen E. coli-Stammes Nissle 1917 bei Reizdarm-Subgruppen
    W Kruis, S. Chrubasik, Christiane Stange, J Schulze · 2004 · Zeitschrift für Gastroenterologie
  52. Auswirkung von oral verabreichtem Escherichia coli Nissle 1917 auf das Darm-assoziierte Immunsystem des Schweins
    Swantje C. Duncker · 2005